Status:
COMPLETED
W-SUDs for COVID-19
Lead Sponsor:
Woebot Health
Collaborating Sponsors:
Stanford University
National Institute on Drug Abuse (NIDA)
Conditions:
Substance Use Disorders
Alcohol Use Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to test the efficacy of a substance use disorder intervention delivered via a mobile application in an adult population during the COVID-19 pandemic. This study that will...
Eligibility Criteria
Inclusion
- All genders aged 18-65 years
- Access to a smartphone
- Available and committed to engage with app and complete assessments
- Be willing to provide email address (as this is how assessment incentives will be distributed),
- Literate in English (as W-SUDs conversational and video materials will be in English).
Exclusion
- Pregnancy (as W-SUDs will not be specifically developed to address the unique needs of this population)
- History of severe drug/alcohol use
- History of opioid misuse without medication-assisted treatment
- Suicide attempt within the past year
- Opioid overdose within the past year
Key Trial Info
Start Date :
June 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04460027
Start Date
June 22 2020
End Date
November 30 2020
Last Update
December 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94306